VDA-1102 : A Novel Well-Tolerated Treatment For Actinic Keratosis Main Article Content Chaim M Brickman Vered Behar Galit Zelinger Oren M Becker Keywords Abstract Abstract not available. Disclosures: Study sponsored by Vidac Pharma. Copyright 2018 SKIN Article Sidebar Poster PDF Published Dec 17, 2018 DOI https://doi.org/10.25251/skin.2.supp.76 Article Details How to Cite Brickman, C. M., Behar, V., Zelinger, G., & Becker, O. M. (2018). VDA-1102 : A Novel Well-Tolerated Treatment For Actinic Keratosis. SKIN The Journal of Cutaneous Medicine, 2, S76. https://doi.org/10.25251/skin.2.supp.76 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Issue Vol. 2 (2018): Supplemental Issue: Scientific Posters & Abstracts Presented at 2018 Fall Clinical Dermatology Conference®-Las Vegas Section Non-Melanoma Skin Cancers and Benign Cutaneous Tumors This work is licensed under a Creative Commons Attribution 4.0 International License. Authors transfer copyright to the publisher as part of the journal publishing agreement.All reprints are subject to the reprint policy.